{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:09:22Z","timestamp":1783541362953,"version":"3.55.0"},"reference-count":43,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R36 HS026840"],"award-info":[{"award-number":["R36 HS026840"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["HS026840"],"award-info":[{"award-number":["HS026840"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R36"],"award-info":[{"award-number":["R36"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TL1 TR001454"],"award-info":[{"award-number":["TL1 TR001454"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR001454"],"award-info":[{"award-number":["TL1 TR001454"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["agsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES<\/jats:title>\n                    <jats:p>To evaluate the prevalence and factors associated with statin pharmacotherapy in long\u2010stay nursing home residents with life\u2010limiting illness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN<\/jats:title>\n                    <jats:p>Cross\u2010sectional.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING<\/jats:title>\n                    <jats:p>US Medicare\u2010 and Medicaid\u2010certified nursing home facilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS<\/jats:title>\n                    <jats:p>Long\u2010stay nursing home resident Medicare fee\u2010for\u2010service beneficiaries aged 65\u2009years or older with life\u2010limiting illness (n = 424 212).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS<\/jats:title>\n                    <jats:p>Prevalent statin use was estimated as any low\u2010moderate intensity (daily dose low\u2010density lipoprotein\u2010cholesterol [LDL\u2010C] reduction &lt;30%\u201050%) and high\u2010intensity (daily dose LDL\u2010C reduction &gt;50%) use via Medicare Part D claims for a prescription supply on September 30, 2016, with a 90\u2010day look\u2010back period. Life\u2010limiting illness was operationally defined to capture those near the end of life using evidence\u2010based criteria to identify progressive terminal conditions or limited prognoses (&lt;6 mo). Poisson models provided estimates of adjusted prevalence ratios and 95% confidence intervals for resident factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 34% of residents with life\u2010limiting illness were prescribed statins (65\u201075\u2009y = 44.0%, high intensity = 11.1%; &gt;75\u2009y = 31.1%, high intensity = 5.4%). Prevalence of statins varied by life\u2010limiting illness definition. Of those with a prognosis of less than 6 months, 23% of the 65 to 75 and 12% of the older than 75 age groups were on statins. Factors positively associated with statin use included minority race or ethnicity, use of more than five concurrent medications, and atherosclerotic cardiovascular disease or risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      Despite having a life\u2010limiting illness, more than one\u2010third of clinically compromised long\u2010stay nursing home residents remain on statins. Although recent national guidelines have expanded indications for statins, the benefit of continued therapy in an advanced age population near the end of life is questionable. Efforts to deprescribe statins in the nursing home setting may be warranted.\n                      <jats:bold>J Am Geriatr Soc 68:708\u2013716, 2020<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jgs.16336","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T07:50:46Z","timestamp":1581666646000},"page":"708-716","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prevalent Statin Use in Long\u2010Stay Nursing Home Residents with Life\u2010Limiting Illness"],"prefix":"10.1111","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8619-0364","authenticated-orcid":false,"given":"Deborah S.","family":"Mack","sequence":"first","affiliation":[{"name":"Division of Epidemiology, Department of Population and Quantitative Health Sciences University of Massachusetts Medical School  Worcester Massachusetts"},{"name":"Clinical and Population Health Research Program Graduate School of Biomedical Sciences, University of Massachusetts Medical School  Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tjia","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Population and Quantitative Health Sciences University of Massachusetts Medical School  Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Hume","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice College of Pharmacy, University of Rhode Island  Kingston Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate L.","family":"Lapane","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Population and Quantitative Health Sciences University of Massachusetts Medical School  Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"American Heart Association. Older Americans and Cardiovascular Diseases: Statistical Fact Sheet.2013.https:\/\/www.heart.org\/idc\/groups\/heart-public\/@wcm\/@sop\/@smd\/documents\/downloadable\/ucm_319574.pdf. Accessed May 9 2018."},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2012.03909.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03490110055029"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.33"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2010.03305.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.15212"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.1442"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31942-1"},{"issue":"1","key":"e_1_2_6_10_1","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"2011","author":"Taylor F","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15063"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15449"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2014.04.001"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.1457"},{"key":"e_1_2_6_15_1","unstructured":"US Preventive Services Task Force. Final update summary: statin use for the primary prevention of cardiovascular disease in adults: preventive medication. US Preventive Services Task Force. 2016.https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/UpdateSummaryFinal\/statin\u2010use\u2010in\u2010adults\u2010preventive\u2010medication1. Accessed December 10 2018."},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.4700"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13105"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2007.0215"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15013"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0289"},{"key":"e_1_2_6_21_1","unstructured":"American Medical Directors Association. Choosing wisely: don't routinely prescribe lipid\u2010lowering medications in individuals with a limited life expectancy. American Family Physician 2019.https:\/\/www.aafp.org\/afp\/recommendations\/viewRecommendation.htm?recommendationId=98. Accessed August 16 2019."},{"key":"e_1_2_6_22_1","unstructured":"SalibaD BuchananJ BuchannanJ. Development and validation of a revised nursing home assessment tool: MDS 3.0. Santa Monica CA; 2008.http:\/\/www.geronet.med.ucla.edu\/centers\/borun\/Appendix_A-G.pdf."},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2012.06.002"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2013.02.021"},{"key":"e_1_2_6_25_1","unstructured":"42 U.S. Code \u00a7 1395x \u2010 Definitions.https:\/\/www.law.cornell.edu\/uscode\/text\/42\/1395x. Accessed October 28 2019."},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2016.0363"},{"key":"e_1_2_6_27_1","first-page":"52","volume-title":"A Toolkit for Developing Hospice and Palliative Care Programs in the Department of Veterans Affairs Medical Centers","author":"Kumar G","year":"2001"},{"key":"e_1_2_6_28_1","first-page":"15","volume-title":"Journey of Change III","author":"Veterans Health Administration","year":"2000"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2019.03.006"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.002"},{"key":"e_1_2_6_31_1","unstructured":"Center for Drug Evaluation and Research. FDA Drug Safety Communication: New restrictions contraindications and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury. US FDA 2011.https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm256581.htm. Accessed February 12 2019."},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.025"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000334"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/54.11.M546"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4497-4"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12479"},{"issue":"8","key":"e_1_2_6_37_1","first-page":"430","article-title":"Impact of the new ACC\/AHA guidelines on the treatment of high blood cholesterol in a managed care setting","volume":"7","author":"Tran JN","year":"2014","journal-title":"Am Health Drug Benefits"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14207"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16227"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2012.04188.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0324"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.827660"},{"key":"e_1_2_6_43_1","unstructured":"Centers for Medicare and Medicaid Services (CMS). Appendix PP \u2010Guidance to Surveyors for Long Term Care Facilities F329 \u00a7483.25 (I) Unnecessary Drugs. State Operations Manual (SOM) Pub 100\u201007. 2017.https:\/\/www.cms.gov\/Regulations\u2010and\u2010Guidance\/Legislation\/CFCsAndCoPs\/Downloads\/som107ap_pp_guidelines_ltcfpdf."},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15616"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjgs.16336","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.16336","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jgs.16336","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.16336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:49:16Z","timestamp":1762188556000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/jgs.16336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1111\/jgs.16336"],"URL":"https:\/\/doi.org\/10.1111\/jgs.16336","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"2019-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}